Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ATAMAX 4 MG/ML SOLUCION ORAL EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ATAMAX 4 MG/ML SOLUCION ORAL EFG

Approved

STANDARD

ATAMAX 4 MG/ML SOLUCION ORAL EFG

Laboratorios Rubio S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 16, 2021
Approval ID: e9250a644a3b67f8
Company: Laboratorios Rubio S.A.
Type: Standard

Approval Details

Approval Id: e9250a644a3b67f8
Drug Cima Aemps Name: ATAMAX 4 MG/ML SOLUCION ORAL EFG
Register Number: 85776
Holder Company Name: Laboratorios Rubio S.A.
Marketing Company Name: Laboratorios Rubio S.A.
Authorization Date: 2021-02-16
Dosage Form: SOLUCIÓN ORAL
Dose: 4 mg/ml
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Laboratorios Rubio S.A.

Active Ingredients

ATOMOXETINA HIDROCLORURO

4,57 mg/ml

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 16, 2021

Approval ID

e9250a644a3b67f8

Type

Standard

Back to CIMA-AEMPS Approvals